H Lundbeck A/S (HLUN-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.014x

Based on the latest financial reports, H Lundbeck A/S (HLUN-B) has a cash flow conversion efficiency ratio of 0.014x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr338.00 Million ≈ $52.88 Million USD) by net assets (Dkr24.90 Billion ≈ $3.90 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

H Lundbeck A/S - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how H Lundbeck A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

H Lundbeck A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of H Lundbeck A/S ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for H Lundbeck A/S (2004–2025)

The table below shows the annual cash flow conversion efficiency of H Lundbeck A/S from 2004 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Dkr24.90 Billion
≈ $3.90 Billion
Dkr4.90 Billion
≈ $766.33 Million
0.197x +47.90%
2024-12-31 Dkr25.01 Billion
≈ $3.91 Billion
Dkr3.33 Billion
≈ $520.38 Million
0.133x -28.14%
2023-12-31 Dkr22.05 Billion
≈ $3.45 Billion
Dkr4.08 Billion
≈ $638.35 Million
0.185x +9.28%
2022-12-31 Dkr20.78 Billion
≈ $3.25 Billion
Dkr3.52 Billion
≈ $550.57 Million
0.169x +36.25%
2021-12-31 Dkr18.28 Billion
≈ $2.86 Billion
Dkr2.27 Billion
≈ $355.47 Million
0.124x -45.02%
2020-12-31 Dkr16.97 Billion
≈ $2.66 Billion
Dkr3.84 Billion
≈ $600.33 Million
0.226x +26.11%
2019-12-31 Dkr14.55 Billion
≈ $2.28 Billion
Dkr2.61 Billion
≈ $408.20 Million
0.179x -57.29%
2018-12-31 Dkr14.25 Billion
≈ $2.23 Billion
Dkr5.98 Billion
≈ $935.77 Million
0.420x +26.38%
2017-12-31 Dkr12.18 Billion
≈ $1.91 Billion
Dkr4.04 Billion
≈ $632.87 Million
0.332x +2.98%
2016-12-31 Dkr9.69 Billion
≈ $1.52 Billion
Dkr3.13 Billion
≈ $489.09 Million
0.322x +1338.01%
2015-12-31 Dkr8.79 Billion
≈ $1.37 Billion
Dkr197.00 Million
≈ $30.82 Million
0.022x -81.16%
2014-12-31 Dkr13.53 Billion
≈ $2.12 Billion
Dkr1.61 Billion
≈ $251.90 Million
0.119x -57.32%
2013-12-31 Dkr13.48 Billion
≈ $2.11 Billion
Dkr3.76 Billion
≈ $588.28 Million
0.279x +74.29%
2012-12-31 Dkr13.20 Billion
≈ $2.06 Billion
Dkr2.11 Billion
≈ $330.44 Million
0.160x -43.59%
2011-12-31 Dkr12.78 Billion
≈ $2.00 Billion
Dkr3.62 Billion
≈ $567.00 Million
0.284x -3.37%
2010-12-31 Dkr11.12 Billion
≈ $1.74 Billion
Dkr3.27 Billion
≈ $510.83 Million
0.294x -14.82%
2009-12-31 Dkr8.80 Billion
≈ $1.38 Billion
Dkr3.03 Billion
≈ $474.69 Million
0.345x -5.88%
2008-12-31 Dkr7.59 Billion
≈ $1.19 Billion
Dkr2.78 Billion
≈ $434.98 Million
0.366x -2.72%
2007-12-31 Dkr7.18 Billion
≈ $1.12 Billion
Dkr2.70 Billion
≈ $423.19 Million
0.376x +82.69%
2006-12-31 Dkr6.76 Billion
≈ $1.06 Billion
Dkr1.39 Billion
≈ $218.10 Million
0.206x -25.47%
2005-12-31 Dkr7.49 Billion
≈ $1.17 Billion
Dkr2.07 Billion
≈ $324.10 Million
0.277x -19.06%
2004-12-31 Dkr7.84 Billion
≈ $1.23 Billion
Dkr2.68 Billion
≈ $418.96 Million
0.342x --

About H Lundbeck A/S

CO:HLUN-B Denmark Drug Manufacturers - Specialty & Generic
Market Cap
$5.50 Billion
Dkr35.14 Billion DKK
Market Cap Rank
#3356 Global
#21 in Denmark
Share Price
Dkr44.30
Change (1 day)
+2.50%
52-Week Range
Dkr29.64 - Dkr47.34
All Time High
Dkr90.49
About

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat maj… Read more